Vicarious Surgical Insider Sells 239 RBOT Shares in Mandatory Tax Withholding

Rhea-AI Filing Summary

Vicarious Surgical Inc. (RBOT) Form 4: insider sale to cover taxes

Khalifa Sammy, listed as Chief Technology Officer, Director and a 10% owner, reported a sale of 239 shares of Class A common stock on 09/03/2025 at a weighted average price of $5.7195 per share. The filing states the sale was a mandatory "sell to cover" to satisfy tax withholding on restricted stock units granted June 2, 2023, and therefore was not a discretionary trade. After the transaction, the reporting person beneficially owned 34,515 shares. The filer signed via attorney-in-fact on 09/04/2025.

Positive

• Transaction disclosed as mandatory sell-to-cover, indicating the sale was for tax withholding, not a discretionary insider disposition
• Clear reporting of weighted average sale price range and offer to provide per-trade details on request, supporting transparency
• Form 4 filed promptly and signed (via attorney-in-fact), showing compliance with SEC reporting rules

Negative

• Insider ownership decreased by 239 shares, reducing holdings to 34,515 shares (minor in absolute terms)

Insights

Financial Analyst

TL;DR: Small, non-discretionary sell-to-cover reduces insider holdings modestly; not materially dilutive.

The reported 239-share sale represents a routine tax-withholding transaction tied to RSU vesting rather than a voluntary disposition. At a weighted average price of $5.7195, proceeds covered withholding obligations from RSUs granted June 2, 2023. The resulting beneficial ownership of 34,515 shares remains intact. Given the small size of the sale relative to total holdings described, this filing is unlikely to meaningfully affect valuation or signal a change in insider sentiment.

Corporate Governance Expert

TL;DR: Filing shows compliance with company equity plan and SEC reporting requirements; disclosure is clear.

The Form 4 discloses the nature of the sale as a mandatory sell-to-cover under the issuer's equity incentive plan and provides the weighted average price range. The reporting person used an attorney-in-fact to sign the form, consistent with procedural practice. The explanation commits to provide detailed trade-level pricing upon request, which supports transparency for shareholders and regulators.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Khalifa Sammy

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/03/2025		S(1)		239	D	$5.7195(2)	34,515	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

2. This figure is the weighted average sales price of multiple trades ranging from $5.60 to $5.84 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc.full information about the number of shares sold at each separate price upon request.

	/s/ Erin Checka, Attorney-in-Fact	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Khalifa Sammy sell according to the RBOT Form 4?

The filing reports a sale of 239 shares of Class A common stock on 09/03/2025.

Why were the shares sold in the RBOT Form 4?

The sale was a mandatory sell-to-cover transaction to satisfy tax withholding obligations from RSUs granted on June 2, 2023.

At what price were the RBOT shares sold?

The weighted average sales price was reported as $5.7195 per share, with individual trades ranging from $5.60 to $5.84.

How many RBOT shares does the reporting person own after the transaction?

After the transaction, the reporting person beneficially owned 34,515 shares.

Who signed the Form 4 for this transaction?

The Form 4 was signed by /s/ Erin Checka, Attorney-in-Fact on 09/04/2025.